Eric Easom
Gründer bei AN2 THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 31.05.2024
Profil
Eric Easom is the President, Chief Executive Officer & Director of AN2 Therapeutics, Inc., a company he founded in 2017.
He is currently the Director of Resilient Biotics, Inc. since 2019 and the Director of Chagas Disease Foundation since 2018.
Previously, he held positions such as Senior Director-Business Development & Marketing at InteKrin Therapeutics, Inc. from 2007 to 2009, Director at Infectious Disease Research Institute from 2013 to 2014, Marketing Director at Medimmune, Inc. from 2006 to 2007, and Vice President-Neglected Diseases at Anacor Pharmaceuticals LLC from 2009 to 2017.
Mr. Easom completed his undergraduate degree at the University of Louisville and holds an MBA from the Kelley School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AN2 THERAPEUTICS, INC.
4,73% | 15.03.2024 | 1 410 012 ( 4,73% ) | 3 Mio $ | 31.05.2024 |
Aktive Positionen von Eric Easom
| Unternehmen | Position | Beginn |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Gründer | 01.02.2017 |
| Chagas Disease Foundation | Direktor/Vorstandsmitglied | 01.06.2018 |
Resilient Biotics, Inc.
 Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Direktor/Vorstandsmitglied | 01.02.2019 |
Ehemalige bekannte Positionen von Eric Easom
| Unternehmen | Position | Ende |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01.06.2017 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Vorsitzender | 01.01.2013 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Vertrieb & Marketing | 01.01.2009 |
| Medimmune, Inc. | Vertrieb & Marketing | 01.07.2007 |
Ausbildung von Eric Easom
| University of Louisville | Undergraduate Degree |
| Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
| Medimmune, Inc. | Health Technology |
Resilient Biotics, Inc.
Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Commercial Services |
| Chagas Disease Foundation |
